aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform the treatment of disease announced that it has been named to Fast Company’s third annual Next Big Things in Tech list.
aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform the treatment of disease announced that it has been named to Fast Company’s third annual Next Big Things in Tech list.
